Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Feb;42(2):171-5.
doi: 10.1136/jnnp.42.2.171.

Effects of 4-aminopyridine in myasthenia gravis

H Lundh, O Nilsson, I Rosén

Effects of 4-aminopyridine in myasthenia gravis

H Lundh et al. J Neurol Neurosurg Psychiatry. 1979 Feb.

Abstract

A new drug, 4-aminopyridine, was prepared for use in humans and tested by repeated injections in six patients with myasthenia gravis. The drug caused improvement of muscle strength and neuromuscular transmission as demonstrated by clinical observations and repetitive electrical nerve stimulation. The drug was effective in cases without any other treatment as well as in cases undergoing treatment with anticholinesterases. It is concluded that 4-aminopyridine may be of value as a supplementary drug in the treatment of myasthenia gravis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Physiol. 1964 Nov;174:417-34 - PubMed
    1. Eur J Pharmacol. 1977 Apr 21;42(4):411-2 - PubMed
    1. Brain Res. 1978 Sep 22;153(2):307-18 - PubMed
    1. Brain Res. 1977 Nov 11;136(2):387-92 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1109-12 - PubMed

LinkOut - more resources